Covestro and PharmaJet work to eliminate the sting in vaccinations

Covestro, a leading polymer company, is proud to announce its collaboration with PharmaJet, a leading biotech company in needle-free injection technology
.
PharmaJet's Needle-Free Injection System (NFIS) offers a more efficient way of injecting drugs and biologics and is favored by patients, caregivers and healthcare professionals
.
NFIS is used as a mode of administration for more than 20 COVID vaccine development projects, as well as the world's first plasmid-based DNA vaccine, which was recently granted emergency use authorization for COVID in India
.

The PharmaJet system required a polycarbonate material that would meet the specifications of the syringe and vial adapters while being sterilized by gamma radiation and ethylene oxide
.
Despite supply chain issues affecting many medical suppliers, Covestro was able to support PharmaJet's material needs
.

Covestro has more than 50 years of experience producing polycarbonates for the medical device industry
.
This product and partnership demonstrates the company's leadership in this market and the breadth of its product portfolio
.
Covestro's range of biocompatible medical-grade products are used in everything from venous access components to surgical instruments to drug delivery solutions
.

Chris Cappello, President and CEO of PharmaJet, said: "We needed a polycarbonate resin that was suitable for our biotech applications and from a supplier we could trust
.
In the fight against COVID-19, Covestro is helping PharmaJet Great support has been provided, enabling the collaboration to achieve better immune outcomes than needle and syringe delivery
.
"

Mark Nichols, Key Account Manager Healthcare at Covestro, said: "Covestro is proud to offer reliable Makrolon® polycarbonate to meet the needs of needle-free injections, ultimately resulting in a better patient experience and less waste
.
"